Entering text into the input field will update the search result below

Pacira BioSciences, Inc. (PCRX) CEO Dave Stack on Q2 2021 Results - Earnings Call Transcript

Aug. 03, 2021 8:09 PM ETPacira BioSciences, Inc. (PCRX)
SA Transcripts profile picture
SA Transcripts

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2021 Earnings Conference Call August 3, 2021 8:30 AM ET

Company Participants

Susan Mesco - IR

Dave Stack - Chairman and CEO

Charlie Reinhart - CFO

Roy Winston - Interim Chief Medical Officer

Conference Call Participants

Daniel Busby - RBC Capital Markets

David Amsellem - Piper Sandler

Christopher Neyor - JPMorgan

David Steinberg - Jefferies

Anita Dushyanth - Berenberg Capital

Andreas Argyrides - Wedbush Securities

Greg Fraser - Truist Securities

Serge Belanger - Needham & Company

Gary Nachman - BMO Capital

Tim Chiang - Northland Capital


Good day, and thank you for standing by. Welcome to the Q2 2021 Pacira BioSciences, Inc. Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Susan Mesco, Head of Investor Relations. Please go ahead.

Susan Mesco

Thank you, Dawn, and good morning, everyone. Welcome to today's conference call to discuss our second quarter progress. Joining me as speakers on today's call are Dave Stack, Chairman and Chief Executive Officer; and Charlie Reinhart, Chief Financial Officer. Additional members of the Pacira executive leadership team are also here for our question-and-answer session.

Before we begin, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today and may involve risks and uncertainties. For information concerning risk factors that could affect the company, please refer to our filings with the SEC, which are available from the SEC or our website.

With that, I will now turn the call over to Dave Stack.

Dave Stack

Thank you, Susan. Good morning, everyone, and thank you for joining us. We are taking a new approach on today's call and will limit our prepared remarks to a few key

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.